Purchase Order 1243YK20P0002
- Not listed
- The U.S. government awarded a delivery order valued at $11,487.12 to Illumina, Inc. for two preventative maintenance visits servicing MiSeq genetic sequencers at a facility in Athens, Georgia. The contract, awarded July 2, 2025, with an ultimate completion date of October 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The funding agency is a civilian entity within the Southeast Area, reflecting Illumina's established role as a critical supplier of...
- The U.S. General Services Administration's Office of Administrative Services Procurement Management Branch awarded a $50,596.30 firm fixed price purchase order to Illumina, Inc. on May 11, 2016, for Illumina maintenance services with an ultimate completion date of January 1, 2018. The contract, which carries no set-aside designation, will be performed in Athens, Georgia. Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis...
- Illumina, Inc. was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $15,965.00 for maintenance services on comprehensive MiSeq equipment. The contract was awarded on November 9, 2015, with an ultimate completion date of September 9, 2019, and will be performed in Athens, Georgia. This maintenance agreement supports a civilian federal agency within the Southeast Area region. No set-aside designation was utilized for this award, reflecting Illumina's specialized...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a delivery order valued at $24,830.22 by a civilian federal agency within the Southeast Area on September 15, 2020. This firm fixed-price contract, with an ultimate completion date of October 30, 2020, required delivery of Illumina's sequencing products or services to Athens, Georgia. The contract was issued without set-aside designation, consistent with...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...
- Illumina, Inc. was awarded a contract call valued at $361,997.78 against an existing Blanket Purchase Agreement (BPA AG-32SC-B-014-0005) to supply Illumina sequencing equipment and related products to the Eastern Laboratory in Athens, Georgia. The contract, awarded on September 5, 2018, with a completion date of September 9, 2019, represents a firm fixed-price procurement with no set-aside designation. The funding agency is the Office of Administrative Services Procurement Management Branch, a...
- Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a delivery order contract valued at $246,163.52 by the Office of Administrative Services Procurement Management Branch on November 24, 2020. This firm fixed-price contract (1232SA20D0001) does not utilize a set-aside designation and was completed by March 23, 2021. The contract covers laboratory equipment, consumables, and services for performance in Athens,...
- This firm fixed-price purchase order was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, by the Centers for Disease Control and Prevention (CDC) in Chamblee, Georgia. The $54,925.69 contract is for ILLUMINA EQUIPMENT MAINTENANCE services with a completion date of December 21, 2025. Illumina has a history of providing sequencing instruments, reagents, and bioinformatics products to support genomic research and diagnostics...
- Illumina, Inc. was awarded a $78,115 firm fixed-price purchase order by the Office of Acquisitions and Grants on January 12, 2023, for maintenance support services on a MiSeq M06789 sequencing instrument. The contract establishes a base period plus four option years, with an ultimate completion date of February 22, 2028. The award includes an estimated annual uplift of 4% applied at each option year exercise, with pricing adjusted downward if manufacturer list prices decrease below quoted...
- On November 20, 2023, the USDA Agricultural Research Service awarded a firm fixed-price purchase order valued at $80,467.62 to Illumina, Inc. for genomic sequencing services. The contract, which will be performed in Athens, Georgia, covers the determination of whole genomic sequences, amplicon sequences, and transcriptome sequences. The solicitation, posted on October 26, 2023, sought quotes for Illumina MiSeq Silver Package Maintenance services with a one-year base term and four optional...
Illumina, Inc. was awarded a purchase order valued at $12,587.48 for maintenance renewal services on Illumina sequencing equipment. The contract, issued on December 12, 2019, with an ultimate completion date of December 15, 2020, represents a firm fixed-price agreement with no set-aside designation. The work will be performed in Athens, Georgia, and is funded through a civilian federal agency's Southeast Area office. As a specialized biotechnology company headquartered in San Diego, California, Illumina provides critical genomic sequencing technologies and related maintenance services to multiple federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and the Department of Agriculture (USDA). This maintenance renewal contract aligns with Illumina's established role as a key supplier of genomic sequencing platforms and support services across the federal government. The company maintains a significant $45 million Indefinite Delivery Contract with the USDA through June 22, 2030, which provides comprehensive access to Illumina's DNA and RNA sequencing instruments, reagents, consumables, and maintenance services. The Athens, Georgia location suggests the equipment supports research activities at a federal facility or institution within the Southeast region, with the maintenance services ensuring continued operational capability of Illumina's advanced sequencing platforms for scientific research and analysis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 2/12/20 |